STExFx: Short-term Working Memory and Executive Training
Study Details
Study Description
Brief Summary
Cognitive remediation (CR) therapies refer to a number of recent developments to use behavioural strategies to improve neurocognitive abilities and improve everyday functioning in mental disorders such as schizophrenia, bipolar disorder, and depression. In this study, we aim to examine whether we can observe CR effects on measures of neuroplasticity, cognition, and functioning when using a rigorous control comparison group. We hypothesize that the active group will exhibit improvements in executive functioning composite scores, improved EEG theta-gamma frequency modulation, and increased EEG alpha power compared to the placebo group.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Executive Function Training Two weeks of training of cognitive domain of executive functioning Using online program (Scientific Brain Training Pro) Four exercises |
Behavioral: Executive Function Training
|
Placebo Comparator: Placebo Training Two weeks of training with exercises not affecting working memory, information processing speed, or cognitive load Exercises maintain other traditional progressive aspects to preserve appearance of dynamic titration of difficulty levels Using online program (Scientific Brain Training Pro) Four exercises |
Behavioral: Placebo
Placebo version of executive function training
|
Outcome Measures
Primary Outcome Measures
- Change from baseline executive functioning composite score at post-treatment assessment [Pre-training assessment (Week 1) and post-training assessment (Week 4)]
Composite score based on four tests of cognition
Secondary Outcome Measures
- Change from baseline EEG theta-gamma frequency modulation at post-treatment assessment [Pre-training assessment (Week 1) and post-training assessment (Week 4)]
Predicted to improve in active CR (cognitive remediation) condition compared to placebo CR
- Change from baseline EEG alpha power at post-treatment assessment [Pre-training assessment (Week 1) and post-training assessment (Week 4)]
Predicted to increase in active CR (cognitive remediation) condition compared to placebo CR
Eligibility Criteria
Criteria
Inclusion Criteria:
-
diagnosis of a chronic mental disorder (defined herein as bipolar disorder, major depressive disorder, or a schizophrenia-spectrum disorder)
-
between the ages of 18 and 65
-
speak and read fluent English
-
able to use a computer
Exclusion Criteria:
-
active substance abuse or dependence diagnosis
-
sensory or motor issues that would preclude completion of study procedures
-
enrollment in a cognitive remediation program or use of cognitive training programs (e.g. lumosity.com) within the past 6 months
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Queen's University | Kingston | Ontario | Canada | K7L3N6 |
Sponsors and Collaborators
- Queen's University
Investigators
- Principal Investigator: Christopher Bowie, PhD, CPsych, Queen's University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- GPSYC-651-14